FDA warning to manufacturers of AIDS drugsBMJ 2001; 322 doi: https://doi.org/10.1136/bmj.322.7295.1143/b (Published 12 May 2001) Cite this as: BMJ 2001;322:1143
- Deborah Josefson
- San Francisco
The US Food and Drug Administration (FDA) has issued a warning letter to manufacturers of AIDS drugs cautioning them to tone down the optimistic tenor of their antiretroviral drug advertisements.
Thomas Abrams, director of the FDA's division of drug marketing, advertising, and communications said that current antiretroviral advertisements directed at consumers are misleading as they fail to depict the limitations of AIDS drugs and also feature healthy looking people who are not representative of typical patients with AIDS. The advertisements therefore violate the Federal Food and Drug Act.
The FDA's letter stated that many …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial